My NCBI | Sign In
RSS Settings
  • Search: O’Neal DN[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia.

    Luke JN, Brown A, O'Neal DN, O'Dea K, Jenkins AJ, Kelaher M, Best JD, Rowley KG.

    Med J Aust. 2009 May 18;190(10):552-6.PMID: 19450200 [PubMed - indexed for MEDLINE]Related articles

    2.

    Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

    O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ.

    Diabetologia. 2009 Jul;52(7):1250-7. Epub 2009 Apr 25.PMID: 19396424 [PubMed - indexed for MEDLINE]Related articles

    3.

    Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles.

    O'Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD, O'Dea K.

    Atherosclerosis. 2008 Dec;201(2):368-77. Epub 2008 Apr 6.PMID: 18599067 [PubMed - indexed for MEDLINE]Related articles

    4.

    Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus.

    Januszewski AS, Thomas MC, Karschimkus CS, Chung JS, Rowley KG, Nelson CL, O'Neal DN, Dragicevic G, Harper CA, Best JD, Jenkins AJ.

    J Med Invest. 2008 Feb;55(1-2):29-36.PMID: 18319542 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

    Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

    Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.PMID: 17971181 [PubMed - indexed for MEDLINE]Related articles

    6.

    Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.

    Davey RA, Tebbutt NC, Favaloro JM, O'neal DN, Rae D, Zajac JD, Best JD.

    Lipids Health Dis. 2006 Dec 17;5:29.PMID: 17173705 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Octreotide treatment of severe diabetic diarrhoea.

    Meyer C, O'Neal DN, Connell W, Alford F, Ward G, Jenkins AJ.

    Intern Med J. 2003 Dec;33(12):617-8. No abstract available. PMID: 14656240 [PubMed - indexed for MEDLINE]Related articles

    8.

    A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb.

    O'Neal DN, Dragicevic G, Rowley KG, Ansari MZ, Balazs N, Jenkins A, Best JD.

    Diabetes Care. 2003 Jan;26(1):199-205.PMID: 12502681 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Diabetic dyslipidaemia: current treatment recommendations.

    Best JD, O'Neal DN.

    Drugs. 2000 May;59(5):1101-11. Review.PMID: 10852642 [PubMed - indexed for MEDLINE]Related articles

    10.

    Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

    Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ.

    Am J Clin Nutr. 2000 May;71(5):1085-94.PMID: 10799369 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.

    O'Neal DN, Hew FL, Best JD, Alford F.

    Growth Horm IGF Res. 1999 Jun;9(3):165-73.PMID: 10502452 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.

    O'Neal DN, O'Brien RC, Timmins KL, Grieve GD, Lau KP, Nicholson GC, Kotowicz MA, Best JD.

    Diabet Med. 1998 Oct;15(10):870-7.PMID: 9796889 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.

    O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD.

    Atherosclerosis. 1998 Jan;136(1):1-8.PMID: 9544725 [PubMed - indexed for MEDLINE]Related articles

    14.

    Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes.

    O'Brien SF, Watts GF, Playford DA, Burke V, O'Neal DN, Best JD.

    Diabet Med. 1997 Nov;14(11):974-8.PMID: 9400923 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.

    O'Neal DN, Kalfas A, Dunning PL, Christopher MJ, Sawyer SD, Ward GM, Alford FP.

    J Clin Endocrinol Metab. 1994 Oct;79(4):975-83.PMID: 7962308 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diabetes and vascular disease.

    Best JD, O'Neal DN.

    Aust Fam Physician. 1993 Sep;22(9):1563, 1566-71.PMID: 8240120 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity